Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide for COVID-19 Progression Prevention
NCT04388683Phase 2Terminated
- Sponsor
- Tufts Medical Center
- Start
- May 2020
- Primary completion
- Nov 2020
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in coronavirus disease 2019 (COVID-19), sponsored by Tufts Medical Center. Started May 2020; status: terminated.
02
Drugs
nitric oxide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04388683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04388683.